EPIXPRESS is a lyophilized human placental-based allograft that includes the amnion layer, intermediate layer, and chorion layer.
INTENDED USES: EPIXPRESS is intended for use as a barrier to provide a protective environment in acute and chronic wounds. The following clinical applications demonstrate the wide range of EPIXPRESS: Acute Wounds, Chronic Wounds, Post-Debridement, Dehisced Wounds, Diabetic Foot Ulcers (DFUs), Venous Leg Ulcers (VLUs), Pressure Ulcers (PUs), Mohs Repair, Deep or Tunneling Wounds
CLAIMED BENEFITS: EPIXPRESS provides a biocompatible human Extracellular Matrix (ECM) and contains 300+ regulatory proteins. Easy to apply. Fenestrated to help facilitate fluid movement. Shelf-stable. 5-year shelf life. Terminally sterilized for additional level of safety. Compatible with compression therapy, Negative Pressure Wound Therapy (NPWT) and Hyperbaric Oxygen Therapy (HBOT)
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care